Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
Fax 1.858.633.0166    Email 
menu1 Home Products Ordering Company Help menu7
   MyBioSource  rightarrow Monoclonal Antibody Blog  rightarrow anti-MDM2 antibody  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Blogs moreseparator
 • anti-KLK3 antibody blog
 • anti-NK cell antibody blog
 • anti-GC antibody blog
 • anti-SLC5A5 antibody blog
 • anti-CEA antibody blog
 • anti-FCER1A antibody blog
 • anti-CD19 antibody blog
 • anti-IFNb antibody blog
 • anti-CD22 antibody blog
 • anti-B7-H3/CD276 antibody blog
 • anti-HSPB2 antibody blog
 • anti-Lplunc1 antibody blog
 • anti-UQCRC1 antibody blog
 • anti-Dlg4 antibody blog
 • anti-AGE-4 antibody blog
 • anti-PEG antibody blog
 • anti-EMD antibody blog
 • anti-IL1a antibody blog
 • anti-IFI35 antibody blog
 • anti-S100A4 antibody blog
Blog Categories separator
 • Assay Kit Blogs
 • Biochemical Blogs
 • cDNA Clone Blogs
 • Monoclonal Antibody Blogs
 • Polyclonal Antibody Blogs
 • Rec/Purified Protein Blogs
 • Popular Product Blogs
Our Best Sellers moreseparator
 • Troponin I, fast skeletal muscle (TNNI2) ELISA Kit
 • 8-hydroxy-2-deoxyguanosine (8-OHdG) ELISA Kit
 • SLP-76 Antibody
 • DcR1 (ED2) (Dcr-1) Antibody
 • Nerve Growth Factor Receptor, p75NTR- FITC (ngfr) Antibody
 • beta-III-Tubulin (Ser-444) Antibody
 • KATII - AADAT Antibody
 • MMP-12 ELISA Kit
 • Free Tri-iodothyronine Indes, Free-T3 (FT3) ELISA Kit
 • absent in melanoma 2 (AIM2) ELISA Kit
 • Pentosidine ELISA Kit
 • Factor VII (F7) Antibody
 • CD172a Antibody
 • Cys-C ELISA Kit
 downarrow more ...

anti-MDM2 antibody product blog

Posted on 2016-06-13 09:19:19 by mybiosource_staff
Share it on ...     
Tags: Antibody; Monoclonal Antibody; anti-MDM2 antibody; MDM2;
The MDM2 mdm2 (Catalog #MBS370312) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The MDM2 reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s MDM2 can be used in a range of immunoassay formats including, but not limited to, Immunohistochemistry (IHC) Formalin/Paraffin. Researchers should empirically determine the suitability of the MDM2 mdm2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.

The MDM2 mdm2 product has the following accession number(s) (GI #155183770) (NCBI Accession #ABT17086.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.

To buy or view more detailed product information and pricing, please click on the technical datasheet page below:

Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the MDM2 with the following immunoassay(s):
Dilution Information
Dilution Information MDM2.

Immunohistochemistry (IHC) (IHC of MDM2 on an FFPE Testicular Cancer Tissue)
Immunohistochemistry (IHC) MDM2.

MDM2 is a protein that in humans is encoded by the MDM2 gene. MDM2 is an important negative regulator of the p53 tumor suppressor. The MDM2 protein functions both as an E3 ubiquitin ligase that recognizes the N-terminal trans-activation domain (TAD) of the p53 tumor suppressor and an inhibitor of p53 transcriptional activation. The human homologue of this protein is sometimes called HDM2. Further supporting the role of MDM2 as an oncogene, several human tumor types have been shown to have increased levels of MDM2, including soft tissue sarcomas and osteosarcomas as well as breast tumors.

Well Differentiated Liposarcomas (WDLPS), Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma (ALT-WDLPS) and Dedifferentiated Liposarcoma (DDLPS) may be difficult to distinguish from benign Adipose Tumors and from Poorly Differentiated Sarcomas, respectively. Genetically, they are characterized by amplification of MDM2 and CDK4 genes on chromosome 12q13-15. MDM2 and CDK4 protein overexpression have also been identified in these tumors. Detection of MDM2/CDK4 protein overexpression by IHC can be used to diagnose WDLPS and DDLPS. Considering a strong and diffuse immunostaining pattern in most of the neoplastic cells achieves the best results in identifying these tumors. Low-grade Osteosarcoma is a rare malignancy that may be subdivided into two main subgroups on the basis of location in relation to the bone cortex, that is, Parosteal Osteosarcoma and Low-grade Central Osteosarcoma. Their histological appearance is quite similar and characterized by spindle cell stroma with low-to-moderate cellularity and well-differentiated anastomosing bone trabeculae. Immunohistochemical expression of MDM2 and CDK4 is specific and provides sensitive markers for the diagnosis of Low-grade Osteosarcomas, helping to differentiate them from benign fibrous and fibro-osseous lesions, particularly in cases with atypical radio-clinical presentation and/or limited biopsy samples.

Localization: Nuclear
Control: Testis, Tonsil, Cervix, Placenta, Liposarcoma, Testicular Cancer.
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions